Biological approaches to ischemic tissue repair: gene- and cell-based strategies

References

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet349(9064), 1498–1504 (1997).
   PubMed Web of Science ®Google Scholar
• Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation115(5), E69–E171 (2007).
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA286(11), 1317–1324 (2001).
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med.9(6), 694–701 (2003).
   PubMed Web of Science ®Google Scholar
• Isner JM. Myocardial gene therapy. Nature415(10), 234–239 (2002).
   PubMed Web of Science ®Google Scholar
• Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy? Curr. Gene Ther.3(3), 197–206 (2003).
   PubMedGoogle Scholar
• Rissanen TT, Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol. Ther.15(7), 1233–1247 (2007).
   PubMed Web of Science ®Google Scholar
• Vincent KA, Jiang C, Boltje I, Kelly RA. Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther.14(10), 781–789 (2007).
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Hilton JD, Arnold JM et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a Phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther.13(21), 1503–1511 (2006).
   PubMed Web of Science ®Google Scholar
• Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation97(12), 1114–1123 (1998).
   PubMed Web of Science ®Google Scholar
• Isner JM, Baumgartner I, Rauh G et al. Treatment of thromboangiitis obliterans (Buerger’s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg.28(6), 964–973; discussion 973–975 (1998).
   PubMed Web of Science ®Google Scholar
• Losordo DW, Vale PR, Symes JF et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation98(25), 2800–2804 (1998).
   PubMed Web of Science ®Google Scholar
• Vale PR, Losordo DW, Milliken CE et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation102(9), 965–974 (2000).
   PubMed Web of Science ®Google Scholar
• Vale PR, Losordo DW, Milliken CE et al. Randomized, single-blind, placebo-controlled pilot study of catheter- based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation103(17), 2138–2143 (2001).
   PubMed Web of Science ®Google Scholar
• Kastrup J, Jorgensen E, Ruck A et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol.45(7), 982–988 (2005).
   PubMed Web of Science ®Google Scholar
• Henry TD, Annex BH, McKendall GR et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation107(10), 1359–1365 (2003).
   PubMed Web of Science ®Google Scholar
• Grines CL, Watkins MW, Helmer G et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation105(11), 1291–1297 (2002).
   PubMed Web of Science ®Google Scholar
• Grines CL, Watkins MW, Mahmarian JJ et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol.42(8), 1339–1347 (2003).
   PubMed Web of Science ®Google Scholar
• Henry TD, Grines CL, Watkins MW et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol.50(11), 1038–1046 (2007).
   PubMed Web of Science ®Google Scholar
• Nikol S, Baumgartner I, Van Belle E et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther.16(5), 972–978 (2008).
   PubMed Web of Science ®Google Scholar
• Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature287(5785), 795–801 (1980).
   PubMed Web of Science ®Google Scholar
• Goodrich LV, Scott MP. Hedgehog and patched in neural development and disease. Neuron21(6), 1243–1257 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson RL, Tabin CJ. Molecular models for vertebrate limb development. Cell90(6), 979–990 (1997).
   PubMed Web of Science ®Google Scholar
• Pepicelli CV, Lewis PM, McMahon AP. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr. Biol.8(19), 1083–1086 (1998).
   PubMed Web of Science ®Google Scholar
• Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development127(12), 2763–2772 (2000).
   PubMed Web of Science ®Google Scholar
• Roelink H, Augsburger A, Heemskerk J et al. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell76(4), 761–775 (1994).
   PubMed Web of Science ®Google Scholar
• St-Jacques B, Dassule HR, Karavanova I et al. Sonic hedgehog signaling is essential for hair development. Curr. Biol.8(19), 1058–1068 (1998).
   PubMed Web of Science ®Google Scholar
• St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev.13(16), 2072–2086 (1999).
   PubMed Web of Science ®Google Scholar
• Xu L, Badolato R, Murphy WJ et al. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J. Immunol.155(3), 1184–1190 (1995).
   PubMed Web of Science ®Google Scholar
• Pola R, Ling LE, Silver M et al. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med.7(6), 706–711 (2001).
   PubMed Web of Science ®Google Scholar
• Kusano KF, Pola R, Murayama T et al. Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat. Med.11(11), 1197–1204 (2005).
   PubMed Web of Science ®Google Scholar
• Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke27(9), 1688–1693 (1996).
   PubMed Web of Science ®Google Scholar
• Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ. Res.77, 7–13 (1995).
   PubMed Web of Science ®Google Scholar
• Rios CD, Ooboshi H, Piegors D, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. Arterioscler. Throm. Vasc. Biol.15, 2241–2245 (1995).
   PubMed Web of Science ®Google Scholar
• Shimamura M, Sato N, Waguri S et al. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension47(4), 742–751 (2006).
   PubMed Web of Science ®Google Scholar
• Yoshimura S, Morishita R, Hayashi K et al. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension39(5), 1028–1034 (2002).
   PubMed Web of Science ®Google Scholar
• Toyoda K, Faraci FM, Watanabe Y et al. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ. Res.87(9), 818–824 (2000).
   PubMed Web of Science ®Google Scholar
• Satoh M, Perkins E, Kimura H et al. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J. Neurosurg.97(1), 136–142 (2002).
   PubMed Web of Science ®Google Scholar
• Stoodley M, Weihl CC, Zhang ZD et al. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery46(5), 1193–1202; discussion 1202–1203 (2000).
   PubMed Web of Science ®Google Scholar
• van Praag H, Schinder AF, Christie BR et al. Functional neurogenesis in the adult hippocampus. Nature415(6875), 1030–1034 (2002).
   PubMed Web of Science ®Google Scholar
• Yarasheski KE, Campbell JA, Smith K et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am. J. Physiol.262(3 Pt 1), E261–E267 (1992).
   Google Scholar
• Cao L, Jiao X, Zuzga DS et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet.36(8), 827–835 (2004).
   PubMed Web of Science ®Google Scholar
• Shimamura M, Sato N, Oshima K et al. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation109(3), 424–431 (2004).
   PubMed Web of Science ®Google Scholar
• Liu G, Li D, Pasumarthy MK et al. Nanoparticles of compacted DNA transfect postmitotic cells. J. Biol. Chem.278(35), 32578–32586 (2003).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275(5302), 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Barile L, Messina E, Giacomello A, Marban E. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis.50(1), 31–48 (2007).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114(6), 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res.95(4), 343–353 (2004).
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol.23(7), 1185–1189 (2003).
   PubMed Web of Science ®Google Scholar
• Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest.105(11), 1527–1536 (2000).
   PubMed Web of Science ®Google Scholar
• Aicher A, Rentsch M, Sasaki K et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res.100(4), 581–589 (2007).
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA97(7), 3422–3427 (2000).
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med.7(4), 430–436 (2001).
   PubMed Web of Science ®Google Scholar
• Masuda H, Kalka C, Takahashi T et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ. Res.101(6), 598–606 (2007).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med.5(4), 434–438 (1999).
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J.18(14), 3964–3972 (1999).
   PubMed Web of Science ®Google Scholar
• Lee SH, Wolf PL, Escudero R et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med.342(9), 626–633 (2000).
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet362(9385), 697–703 (2003).
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med.10(8), 858–864 (2004).
   PubMed Web of Science ®Google Scholar
• Pillarisetti K, Gupta SK. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 α mRNA is selectively induced in rat model of myocardial infarction. Inflammation25(5), 293–300 (2001).
   PubMed Web of Science ®Google Scholar
• Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood103(3), 921–926 (2004).
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell109(5), 625–637 (2002).
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9(11), 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res.85(3), 221–228 (1999).
   PubMed Web of Science ®Google Scholar
• Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med.195(9), 1145–1154 (2002).
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Kusano KF, Masuo O et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation107(9), 1322–1328 (2003).
   PubMed Web of Science ®Google Scholar
• Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med.9(6), 702–712 (2003).
   PubMed Web of Science ®Google Scholar
• Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood92(2), 362–367 (1998).
   PubMed Web of Science ®Google Scholar
• Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation109(21 Suppl. 1), II27–II33 (2004).
   PubMed Web of Science ®Google Scholar
• Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation111(3), 363–368 (2005).
   PubMed Web of Science ®Google Scholar
• Ii M, Nishimura H, Iwakura A et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation111(9), 1114–1120 (2005).
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med.348(7), 593–600 (2003).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Rigolin GM, Fucili A et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation110(10), 1209–1212 (2004).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res.89(1), E1–E7 (2001).
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation111(22), 2981–2987 (2005).
   PubMed Web of Science ®Google Scholar
• Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109(2), 220–226 (2004).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation103(24), 2885–2890 (2001).
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation106(15), 1913–1918 (2002).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Iwasaki H, Kusano K et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation114(20), 2163–2169 (2006).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Britten MB et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol.44(8), 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1210–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet364(9429), 141–148 (2004).
   PubMed Web of Science ®Google Scholar
• Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer To Enhance ST-elevation Infarct Regeneration) trial. Circulation113(10), 1287–1294 (2006).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367(9505), 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur. Heart J.28(6), 766–772 (2007).
   PubMed Web of Science ®Google Scholar
• Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med.167(10), 989–997 (2007).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation107(18), 2294–2302 (2003).
   PubMed Web of Science ®Google Scholar
• Losordo DW, Schatz RA, White CJ et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial. Circulation115(25), 3165–3172 (2007).
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet360(9331), 427–435 (2002).
   PubMed Web of Science ®Google Scholar
• Lau KK, Chan YH, Yiu KH et al. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J. Hum. Hypertens.21(6), 445–451 (2007).
   PubMed Web of Science ®Google Scholar
• Ghani U, Shuaib A, Salam A et al. Endothelial progenitor cells during cerebrovascular disease. Stroke36(1), 151–153 (2005).
   PubMed Web of Science ®Google Scholar
• Yip HK, Chang LT, Chang WN et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke39(1), 69–74 (2008).
   PubMed Web of Science ®Google Scholar
• Sobrino T, Hurtado O, Moro MA et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke38(10), 2759–2764 (2007).
   PubMed Web of Science ®Google Scholar
• Taguchi A, Matsuyama T, Moriwaki H et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation109(24), 2972–2975 (2004).
   PubMed Web of Science ®Google Scholar
• Hess DC, Abe T, Hill WD et al. Hematopoietic origin of microglial and perivascular cells in brain. Exp. Neurol.186(2), 134–144 (2004).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature441(7097), 1094–1096 (2006).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med.10(Suppl.), S42-S50 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res.90(3), 284–288 (2002).
   PubMed Web of Science ®Google Scholar
• Hess DC, Hill WD, Martin-Studdard A et al. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke33(5), 1362–1368 (2002).
   PubMed Web of Science ®Google Scholar
• Shyu WC, Lin SZ, Chiang MF, Su CY, Li H. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing b1 integrin-mediated angiogenesis in chronic stroke rats. J. Neurosci.26(13), 3444–3453 (2006).
   PubMed Web of Science ®Google Scholar
• Shyu WC, Chen CP, Lin SZ, Lee YJ, Li H. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke38(2), 367–374 (2007).
   PubMed Web of Science ®Google Scholar
• Gertz K, Priller J, Kronenberg G et al. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ. Res.99(10), 1132–1140 (2006).
   PubMed Web of Science ®Google Scholar
• Minger SL, Ekonomou A, Carta EM et al. Endogenous neurogenesis in the human brain following cerebral infarction. Regen. Med.2(1), 69–74 (2007).
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol.57(6), 874–882 (2005).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg.103(1), 38–45 (2005).
   PubMed Web of Science ®Google Scholar
• Castro RF, Jackson KA, Goodell MA et al. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science297(5585), 1299 (2002).
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Skinner SJ, Geaney M et al. Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke35(9), 2206–2210 (2004).
   PubMed Web of Science ®Google Scholar
• Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med.8(9), 963–970 (2002).
   PubMed Web of Science ®Google Scholar
• Jin K, Minami M, Lan JQ et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl Acad. Sci. USA98(8), 4710–4715 (2001).
   PubMed Web of Science ®Google Scholar
• Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke38(2 Suppl.), 817–826 (2007).
   PubMed Web of Science ®Google Scholar
• Taguchi A, Soma T, Tanaka H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest.114(3), 330–338 (2004).
   PubMed Web of Science ®Google Scholar
• Krupinski J, Kaluza J, Kumar P, Wang M, Kumar S. Prognostic value of blood vessel density in ischaemic stroke. Lancet342(8873), 742 (1993).
   PubMed Web of Science ®Google Scholar
• Raper SE, Chirmule N, Lee FS et al. Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab.80(1–2), 148–158 (2003).
   PubMed Web of Science ®Google Scholar
• Kurozumi K, Nakamura K, Tamiya T et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther.11(1), 96–104 (2005).
   PubMed Web of Science ®Google Scholar
• Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol.287(3), C572–C579 (2004).
   PubMed Web of Science ®Google Scholar
• Ripa RS, Wang Y, Jorgensen E et al. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur. Heart J.27(15), 1785–1792 (2006).
   PubMed Web of Science ®Google Scholar
• Miyagawa S, Sawa Y, Taketani S et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation105(21), 2556–2561 (2002).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Duarte F, Cattadori B et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J. Thorac. Cardiovasc. Surg.128(2), 245–253 (2004).
   PubMed Web of Science ®Google Scholar
• Stevens KR, Rolle MW, Minami E et al. Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts. Hum. Gene Ther.18(5), 401–412 (2007).
   PubMed Web of Science ®Google Scholar
• Kutschka I, Kofidis T, Chen IY et al. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation114(1 Suppl.), I174–I180 (2006).
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE2, E156 (2007).
   PubMed Web of Science ®Google Scholar
• Wei L, Cui L, Snider BJ et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol. Dis.19(1–2), 183–193 (2005).
   PubMed Web of Science ®Google Scholar
• Abbott JD, Huang Y, Liu D et al. Stromal cell-derived factor-1a plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation110(21), 3300–3305 (2004).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand. Cardiovasc. J.39(3), 150–158 (2005).
   PubMed Web of Science ®Google Scholar
• Hedman M, Hartikainen J, Syvanne M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation107(21), 2677–2683 (2003).
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, van Weel V, Mulder NH et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum. Gene Ther.17(6), 683–691 (2006).
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Mohler ER 3rd, Lederman RJ et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a Phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation108(16), 1933–1938 (2003).
   PubMed Web of Science ®Google Scholar
• Makinen K, Manninen H, Hedman M et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded Phase II study. Mol. Ther.6(1), 127–133 (2002).
   PubMed Web of Science ®Google Scholar
• Powell RJ, Dormandy J, Simons M, Morishita R, Annex BH. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial. Vasc. Med.9(3), 193–198 (2004).
   PubMed Web of Science ®Google Scholar
• Conte MS, Bandyk DF, Clowes AW et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg.43(4), 742–751; discussion 751 (2006).
   PubMed Web of Science ®Google Scholar